An open-label, randomized, multi-center study to evaluate the use of Study Drug in the prevention of cancer treatment-related bone loss in post-menopausal women with ER+ and/or PR+ breast cancer receiving letrozole as adjuvant therapy.
Explore related content and topics
Blog
Virtual Technology Strives to Make Better Research and Treatments for All
The use of virtual reality (VR) technology, wearable technology, and virtual clinical trials can provide researchers with a more convenient way to…
Read Story
Case Study
Early Phase Innovative Pediatric Oncology Program Achieves Successful First Multiple Solid Tumors Study
PRA partnered with the sponsor’s new pediatric oncology department on an innovative pediatric oncology program. The program provided early evaluation…
View Resource
Newsletter
Industry Watch
This week’s issue of Industry Watch is focused on proposed changes to US lung cancer screening guidelines which will hopefully result in increased…
Read More
View all related content and resources for Oncology
Explore Insights